Linda Palczuk joined Osiris on July 10, 2017 as President and Chief Executive Officer. With 30 years of experience in the biopharmaceutical industry, Ms. Palczuk held numerous commercial leadership roles of increasing responsibility at AstraZeneca and its legacy companies. Prior to her appointment at Osiris, Ms. Palczuk served as Vice President, Mature Brands & Global Commercial Excellence; Vice President, Sales & Marketing; and Vice President, Sales. Ms. Palczuk earned a BA in Biology from Franklin and Marshall College in Lancaster, PA and an MBA from the University of Delaware. She is a member of the Healthcare Businesswomen’s Association, where she received their coveted Rising Star Award. Ms. Palczuk was honored with various other external awards including Women of Achievement Award from the National Council on Aging, Top 50 Award from Advertising Age, and Marketer of the Year Award from Brandweek. Linda Palczuk joined Osiris on July 10, 2017 as President and Chief Executive Officer. With 30 years of experience in the biopharmaceutical industry, Ms. Palczuk held numerous commercial leadership roles of increasing responsibility at AstraZeneca and its legacy companies. Prior to her appointment at Osiris, Ms. Palczuk served as Vice President, Mature Brands & Global Commercial Excellence; Vice President, Sales & Marketing; and Vice President, Sales. Ms. Palczuk earned a BA in Biology from Franklin and Marshall College in Lancaster, PA and an MBA from the University of Delaware. She is a member of the Healthcare Businesswomen’s Association, where she received their coveted Rising Star Award. Ms. Palczuk was honored with various other external awards including Women of Achievement Award from the National Council on Aging, Top 50 Award from Advertising Age, and Marketer of the Year Award from Brandweek.

Marketing